The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
Crossref DOI link: https://doi.org/10.1186/s12885-016-2723-1
Published Online: 2016-09-06
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dayyani, Farshid
Zurita, Amado J.
Nogueras-González, Graciela M.
Slack, Rebecca
Millikan, Randall E.
Araujo, John C.
Gallick, Gary E.
Logothetis, Christopher J.
Corn, Paul G.
License valid from 2016-09-06